CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Avisa Diagnostics Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Avisa Diagnostics Inc
1660A Old Pecos Trail
Phone: (505) 820-1400p:505 820-1400 SANTA FE, NM  87505  United States Fax: (505) 226-1500f:505 226-1500
This company is no longer actively traded on any major stock exchange.
Business Summary
Avisa Diagnostics Inc. is a clinical-stage medical device company. The Company is engaged in the development of the Allora BreathTest (ABT), a drug/device biomarker technology platform. The Allora BreathTest (ABT) is an ultra-rapid, point-of-care biomarker breath test for the detection and monitoring of bacterial load. ABT enables the ultra-rapid detection of virulent bacterial pathogens, detecting and monitoring bacterial load after the patient inhales or ingests its drug substrates via its own delivery systems. Its ABT portfolio includes Post-Covid-19 Bronchiectasis, Develo, Ventilator-Associated Pneumonia (VAP), Chronic Obstructive Pulmonary Disease (COPD), Community-Acquired, Pneumonia (CAP), Cystic Fibrosis, Tuberculosis, Aspergillus Fungus and Clostridium Difficile (C. diff).
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202112/31/2020Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
3845 Electromedical and electrotherapeutic apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer Daniel G.Crandall 6/22/2021 8/31/2015
Chief Financial Officer G. M.Landis 6/22/2021 6/22/2021
Secretary, Vice President - Product Marketing AnthonyCerna
4 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Avisa Pharma Inc. 1600A Old Pecos Trail Santa Fe NM United States

Business Names
Business Name
Avisa Pharma Inc.
Lunga Resources (BVI) Limited
Mukuba Resources Ltd.
Quilmont Solutions, Inc.
RadJav

General Information
Outstanding Shares: 58,935,784 (As of 7/21/2021)
Stock Exchange: CNQ
Fax Number: (505) 226-1500


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, April 3, 2024